As cytotoxic CD8+ effector function is highly dependent on CD4+ T-cell cooperation, exploration of cellular and biochemical drivers TH-cell differentiation may hold promise for making resistant cancers more immunogenic. The gene discussed is CD4; the disease is cancer.